The syntheses and in vivo biodistribution of novel boronated unnatural amino acids

Applied Radiation and Isotopes

Volumn 61, Issue 5, 2004, Pages 1111-1115

  Kabalka, G W ^a   Wu, Z Z ^a   Yao, M L ^a   Natarajan, N ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Amino acids; Boronic acid; Neutron capture therapy; Synthesis,biodistribution

Indexed keywords

ADDITION REACTIONS; BLOOD; CATALYSIS; LIVING SYSTEMS STUDIES; PROBABILITY; SYNTHESIS (CHEMICAL); TUMORS;

BIODISTRIBUTIONS; MELANOMA;

ORGANIC COMPOUNDS;

1 AMINO 3 BORONOCYCLOPENTANECARBOXYLIC ACID; AMINO ACID; BORON DERIVATIVE; CARBOXYLIC ACID DERIVATIVE; METAL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD; BRAIN TUMOR; CATALYSIS; CONFERENCE PAPER; DIASTEREOISOMER; DRUG DISTRIBUTION; DRUG SYNTHESIS; ENANTIOMER; FEMALE; MELANOMA; MOUSE; NEUTRON CAPTURE THERAPY; NONHUMAN; PRIORITY JOURNAL; PROBABILITY; SKIN;

AMINO ACIDS; ANIMALS; BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; FEMALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MOLECULAR STRUCTURE; TISSUE DISTRIBUTION;

EID: 4143093847     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2004.05.012     Document Type: Conference Paper

References (14)

1. Barth R.F., Yang W., Bartus R.T., Rotaru J.H., Ferketich A.K., Moeschberger M.L., Nawrocky M.M., Coderre J.A., Rofstad E.K. Neutron capture therapy of intracerebral melanoma. enhanced survival and cure after blood-brain barrier opening to improve delivery of boronophenylalanine Int. J. Radiat. Oncol. Biol. Phys. 52(3):2002;858-868
2. El-Zaria M.E., Doerfler U., Gabel D. Synthesis of [(aminoalkylamine)-n- aminoalkyl]azanonaborane(11) derivatives for boron neutron capture therapy. J. Med. Chem. 45(26):2002;5817-5819
3. Hawthorne M.F. Applications of radiolabeled boron clusters to the diagnosis and treatment of cancer. Chem. Rev. 99(12):1999;3421-3434
4. 11C]-ACBC) for detecting recurrent brain tumors. Clin. Positron Imag. 1:1998;165-169
5. Isaac M.F., Kahl S.B. Synthesis of ether- and carbon-linked polycarboranyl porphyrin dimers for cancer therapies. J. Organomet. Chem. 680(1-2):2003;232-243
6. Ivanov D., Bachovchin W.W., Redfield A.G. Boron-11 pure quadrupole resonance investigation of peptide boronic acid inhibitors bound to α-lytic protease. Biochem. 41(5):2002;1587-1590
7. Kabalka G.W., Das B.C., Das S. Synthesis of novel boron containing unnatural cyclic amino acids as potential therapeutic agents. Tetrahedron Lett. 42(41):2001;7145-7146
8. Kabalka G.W., Yao M-L. Synthesis of a potential boron neutron capture therapy agent. 1-aminocyclobutane-1-carboxylic acid bearing a butylboronic acid side chain Synthesis. 18:2003;2890-2893
9. Nichols T.L., Kabalka G.W., Miller L.F., Khan M.K., Smith G.T. Improved treatment planning for boron neutron capture therapy for glioblastoma multiforme using fluorine-18 labeled boronophenylalanine and positron emission tomography. Med. Phys. 29(10):2002;2351-2358
10. Olejiniczak A.B., Koziolkiewcz M., Lesnikowski Z.J. Carboranyl oligonucleotides. 4. Synthesis and physicochemical studies of oligonucleotides containing 2′-O-(o-carboran-1-yl)methyl group Antisense Nucleic Acid Drug Dev. 12(2):2002;79-94
11. 13C NMR evidence for the β-D-fructofuranose 2,3,6-(p-phenylalanylorthoboronate) structure J. Pharm. Sci. 89(2):2000;215-222
12. Takahashi K., Ishiyama T., Miyaura N. A borylcopper species generated from bis(pinacolato)diboron and its additions to α,β-unsaturated carbonyl compounds and terminal alkynes. J. Organomet. Chem. 625(1):2001;47-53
13. Tietze L.F., Griesbach U., Schuberth I., Bothe U., Marra A., Dondoni A. Novel carboranyl C-glycosides for the treatment of cancer by boron neutron capture therapy. Chem. - a Eur. J. 9(6):2003;1296-1302
14. Tjarks W. The use of boron clusters in the rational design of boronated nucleosides for neutron capture therapy of cancer. J. Organomet. Chem. 614-615:2001;37-47